APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin API

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

Selected research

Market Analysis & Forecast

Global Insulin API Market Analysis and Forecast 2026-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchInsulin API Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin API Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Insulin API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin API Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

Read the full market overview

The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.

This report presents an overview of global market for Insulin API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Insulin API, also provides the sales of main regions and countries. Of the upcoming market potential for Insulin API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Insulin API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Insulin API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Insulin API sales, projected growth trends, production technology, application and end-user industry.

Insulin API Segment by Company

Novo Nordisk

Sanofi-Aventis

Eli Lilly

Tonghua Dongbao

Ganlee

United Laboratory

Biocon

Amphastar

Wockhardt

Julphar Diabetes

Torrent Pharma

Insulin API Segment by Type

Regular Human Insulin

Insulin Analogue

Insulin API Segment by Application

Fast-Acting

Premix

Long-Acting

Insulin API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Insulin API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Insulin API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insulin API sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Insulin API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Regular Human Insulin Major Manufacturers Table 3. Insulin Analogue Major Manufacturers Table 4. Global Insulin API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Fast-Acting Major Manufacturers Table 6. Premix Major Manufacturers Table 7. Long-Acting Major Manufacturers Table 8. Insulin API Industry Trends Table 9. Insulin API Industry Drivers Table 10. Insulin API Industry Opportunities and Challenges Table 11. Insulin API Industry Restraints Table 12. Global Insulin API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Insulin API Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Insulin API Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Insulin API Revenue Market Share by Region (2021-2026) Table 16. Global Insulin API Revenue Market Share by Region (2027-2032) Table 17. Global Insulin API Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 18. Global Insulin API Sales by Region (2021-2026) & (Kg) Table 19. Global Insulin API Sales by Region (2027-2032) & (Kg) Table 20. Global Insulin API Sales Market Share by Region (2021-2026) Table 21. Global Insulin API Sales Market Share by Region (2027-2032) Table 22. Global Insulin API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Insulin API Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Insulin API Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Insulin API Sales Market Share by Manufacturers (2021-2026) Table 26. Global Insulin API Sales Price (K US$/Kg) of Manufacturers (2021-2026) Table 27. Global Insulin API Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Insulin API Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Insulin API Manufacturers, Product Type & Application Table 30. Global Insulin API Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Insulin API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Insulin API Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Insulin API Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Insulin API Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Insulin API Revenue Market Share by Type (2021-2026) Table 37. Global Insulin API Revenue Market Share by Type (2027-2032) Table 38. Global Insulin API Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 39. Global Insulin API Sales by Type (2021-2026) & (Kg) Table 40. Global Insulin API Sales by Type (2027-2032) & (Kg) Table 41. Global Insulin API Sales Market Share by Type (2021-2026) Table 42. Global Insulin API Sales Market Share by Type (2027-2032) Table 43. Global Insulin API Price by Type (2021-2026) & (K US$/Kg) Table 44. Global Insulin API Price by Type (2027-2032) & (K US$/Kg) Table 45. Global Insulin API Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Insulin API Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Insulin API Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Insulin API Revenue Market Share by Application (2021-2026) Table 49. Global Insulin API Revenue Market Share by Application (2027-2032) Table 50. Global Insulin API Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 51. Global Insulin API Sales by Application (2021-2026) & (Kg) Table 52. Global Insulin API Sales by Application (2027-2032) & (Kg) Table 53. Global Insulin API Sales Market Share by Application (2021-2026) Table 54. Global Insulin API Sales Market Share by Application (2027-2032) Table 55. Global Insulin API Price by Application (2021-2026) & (K US$/Kg) Table 56. Global Insulin API Price by Application (2027-2032) & (K US$/Kg) Table 57. Novo Nordisk Company Information Table 58. Novo Nordisk Business Overview Table 59. Novo Nordisk Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 60. Novo Nordisk Insulin API Product Portfolio Table 61. Novo Nordisk Recent Development Table 62. Sanofi-Aventis Company Information Table 63. Sanofi-Aventis Business Overview Table 64. Sanofi-Aventis Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 65. Sanofi-Aventis Insulin API Product Portfolio Table 66. Sanofi-Aventis Recent Development Table 67. Eli Lilly Company Information Table 68. Eli Lilly Business Overview Table 69. Eli Lilly Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 70. Eli Lilly Insulin API Product Portfolio Table 71. Eli Lilly Recent Development Table 72. Tonghua Dongbao Company Information Table 73. Tonghua Dongbao Business Overview Table 74. Tonghua Dongbao Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 75. Tonghua Dongbao Insulin API Product Portfolio Table 76. Tonghua Dongbao Recent Development Table 77. Ganlee Company Information Table 78. Ganlee Business Overview Table 79. Ganlee Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 80. Ganlee Insulin API Product Portfolio Table 81. Ganlee Recent Development Table 82. United Laboratory Company Information Table 83. United Laboratory Business Overview Table 84. United Laboratory Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 85. United Laboratory Insulin API Product Portfolio Table 86. United Laboratory Recent Development Table 87. Biocon Company Information Table 88. Biocon Business Overview Table 89. Biocon Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 90. Biocon Insulin API Product Portfolio Table 91. Biocon Recent Development Table 92. Amphastar Company Information Table 93. Amphastar Business Overview Table 94. Amphastar Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 95. Amphastar Insulin API Product Portfolio Table 96. Amphastar Recent Development Table 97. Wockhardt Company Information Table 98. Wockhardt Business Overview Table 99. Wockhardt Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 100. Wockhardt Insulin API Product Portfolio Table 101. Wockhardt Recent Development Table 102. Julphar Diabetes Company Information Table 103. Julphar Diabetes Business Overview Table 104. Julphar Diabetes Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 105. Julphar Diabetes Insulin API Product Portfolio Table 106. Julphar Diabetes Recent Development Table 107. Torrent Pharma Company Information Table 108. Torrent Pharma Business Overview Table 109. Torrent Pharma Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 110. Torrent Pharma Insulin API Product Portfolio Table 111. Torrent Pharma Recent Development Table 112. North America Insulin API Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Insulin API Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Insulin API Sales by Type (2021-2026) & (Kg) Table 115. North America Insulin API Sales by Type (2027-2032) & (Kg) Table 116. North America Insulin API Sales Price by Type (2021-2026) & (K US$/Kg) Table 117. North America Insulin API Sales Price by Type (2027-2032) & (K US$/Kg) Table 118. North America Insulin API Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Insulin API Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Insulin API Sales by Application (2021-2026) & (Kg) Table 121. North America Insulin API Sales by Application (2027-2032) & (Kg) Table 122. North America Insulin API Sales Price by Application (2021-2026) & (K US$/Kg) Table 123. North America Insulin API Sales Price by Application (2027-2032) & (K US$/Kg) Table 124. North America Insulin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Insulin API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Insulin API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Insulin API Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 128. North America Insulin API Sales by Country (2021-2026) & (Kg) Table 129. North America Insulin API Sales by Country (2027-2032) & (Kg) Table 130. North America Insulin API Sales Price by Country (2021-2026) & (K US$/Kg) Table 131. North America Insulin API Sales Price by Country (2027-2032) & (K US$/Kg) Table 132. United States Insulin API Revenue (2021-2032) & (US$ Million) Table 133. Canada Insulin API Revenue (2021-2032) & (US$ Million) Table 134. Mexico Insulin API Revenue (2021-2032) & (US$ Million) Table 135. Europe Insulin API Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Insulin API Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Insulin API Sales by Type (2021-2026) & (Kg) Table 138. Europe Insulin API Sales by Type (2027-2032) & (Kg) Table 139. Europe Insulin API Sales Price by Type (2021-2026) & (K US$/Kg) Table 140. Europe Insulin API Sales Price by Type (2027-2032) & (K US$/Kg) Table 141. Europe Insulin API Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Insulin API Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Insulin API Sales by Application (2021-2026) & (Kg) Table 144. Europe Insulin API Sales by Application (2027-2032) & (Kg) Table 145. Europe Insulin API Sales Price by Application (2021-2026) & (K US$/Kg) Table 146. Europe Insulin API Sales Price by Application (2027-2032) & (K US$/Kg) Table 147. Europe Insulin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Insulin API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Insulin API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Insulin API Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 151. Europe Insulin API Sales by Country (2021-2026) & (Kg) Table 152. Europe Insulin API Sales by Country (2027-2032) & (Kg) Table 153. Europe Insulin API Sales Price by Country (2021-2026) & (K US$/Kg) Table 154. Europe Insulin API Sales Price by Country (2027-2032) & (K US$/Kg) Table 155. Germany Insulin API Revenue (2021-2032) & (US$ Million) Table 156. France Insulin API Revenue (2021-2032) & (US$ Million) Table 157. U.K. Insulin API Revenue (2021-2032) & (US$ Million) Table 158. Italy Insulin API Revenue (2021-2032) & (US$ Million) Table 159. Russia Insulin API Revenue (2021-2032) & (US$ Million) Table 160. Spain Insulin API Revenue (2021-2032) & (US$ Million) Table 161. Netherlands Insulin API Revenue (2021-2032) & (US$ Million) Table 162. Switzerland Insulin API Revenue (2021-2032) & (US$ Million) Table 163. Sweden Insulin API Revenue (2021-2032) & (US$ Million) Table 164. Poland Insulin API Revenue (2021-2032) & (US$ Million) Table 165. China Insulin API Revenue by Type (2021-2026) & (US$ Million) Table 166. China Insulin API Revenue by Type (2027-2032) & (US$ Million) Table 167. China Insulin API Sales by Type (2021-2026) & (Kg) Table 168. China Insulin API Sales by Type (2027-2032) & (Kg) Table 169. China Insulin API Sales Price by Type (2021-2026) & (K US$/Kg) Table 170. China Insulin API Sales Price by Type (2027-2032) & (K US$/Kg) Table 171. China Insulin API Revenue by Application (2021-2026) & (US$ Million) Table 172. China Insulin API Revenue by Application (2027-2032) & (US$ Million) Table 173. China Insulin API Sales by Application (2021-2026) & (Kg) Table 174. China Insulin API Sales by Application (2027-2032) & (Kg) Table 175. China Insulin API Sales Price by Application (2021-2026) & (K US$/Kg) Table 176. China Insulin API Sales Price by Application (2027-2032) & (K US$/Kg) Table 177. Asia Insulin API Revenue by Type (2021-2026) & (US$ Million) Table 178. Asia Insulin API Revenue by Type (2027-2032) & (US$ Million) Table 179. Asia Insulin API Sales by Type (2021-2026) & (Kg) Table 180. Asia Insulin API Sales by Type (2027-2032) & (Kg) Table 181. Asia Insulin API Sales Price by Type (2021-2026) & (K US$/Kg) Table 182. Asia Insulin API Sales Price by Type (2027-2032) & (K US$/Kg) Table 183. Asia Insulin API Revenue by Application (2021-2026) & (US$ Million) Table 184. Asia Insulin API Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia Insulin API Sales by Application (2021-2026) & (Kg) Table 186. Asia Insulin API Sales by Application (2027-2032) & (Kg) Table 187. Asia Insulin API Sales Price by Application (2021-2026) & (K US$/Kg) Table 188. Asia Insulin API Sales Price by Application (2027-2032) & (K US$/Kg) Table 189. Asia Insulin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Insulin API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. Asia Insulin API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. Asia Insulin API Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 193. Asia Insulin API Sales by Country (2021-2026) & (Kg) Table 194. Asia Insulin API Sales by Country (2027-2032) & (Kg) Table 195. Asia Insulin API Sales Price by Country (2021-2026) & (K US$/Kg) Table 196. Asia Insulin API Sales Price by Country (2027-2032) & (K US$/Kg) Table 197. Japan Insulin API Revenue (2021-2032) & (US$ Million) Table 198. South Korea Insulin API Revenue (2021-2032) & (US$ Million) Table 199. India Insulin API Revenue (2021-2032) & (US$ Million) Table 200. Australia Insulin API Revenue (2021-2032) & (US$ Million) Table 201. Taiwan Insulin API Revenue (2021-2032) & (US$ Million) Table 202. Southeast Asia Insulin API Revenue (2021-2032) & (US$ Million) Table 203. SAMEA Insulin API Revenue by Type (2021-2026) & (US$ Million) Table 204. SAMEA Insulin API Revenue by Type (2027-2032) & (US$ Million) Table 205. SAMEA Insulin API Sales by Type (2021-2026) & (Kg) Table 206. SAMEA Insulin API Sales by Type (2027-2032) & (Kg) Table 207. SAMEA Insulin API Sales Price by Type (2021-2026) & (K US$/Kg) Table 208. SAMEA Insulin API Sales Price by Type (2027-2032) & (K US$/Kg) Table 209. SAMEA Insulin API Revenue by Application (2021-2026) & (US$ Million) Table 210. SAMEA Insulin API Revenue by Application (2027-2032) & (US$ Million) Table 211. SAMEA Insulin API Sales by Application (2021-2026) & (Kg) Table 212. SAMEA Insulin API Sales by Application (2027-2032) & (Kg) Table 213. SAMEA Insulin API Sales Price by Application (2021-2026) & (K US$/Kg) Table 214. SAMEA Insulin API Sales Price by Application (2027-2032) & (K US$/Kg) Table 215. SAMEA Insulin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. SAMEA Insulin API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. SAMEA Insulin API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. SAMEA Insulin API Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 219. SAMEA Insulin API Sales by Country (2021-2026) & (Kg) Table 220. SAMEA Insulin API Sales by Country (2027-2032) & (Kg) Table 221. SAMEA Insulin API Sales Price by Country (2021-2026) & (K US$/Kg) Table 222. SAMEA Insulin API Sales Price by Country (2027-2032) & (K US$/Kg) Table 223. Brazil Insulin API Revenue (2021-2032) & (US$ Million) Table 224. Argentina Insulin API Revenue (2021-2032) & (US$ Million) Table 225. Chile Insulin API Revenue (2021-2032) & (US$ Million) Table 226. Colombia Insulin API Revenue (2021-2032) & (US$ Million) Table 227. Peru Insulin API Revenue (2021-2032) & (US$ Million) Table 228. Saudi Arabia Insulin API Revenue (2021-2032) & (US$ Million) Table 229. Israel Insulin API Revenue (2021-2032) & (US$ Million) Table 230. UAE Insulin API Revenue (2021-2032) & (US$ Million) Table 231. Turkey Insulin API Revenue (2021-2032) & (US$ Million) Table 232. Iran Insulin API Revenue (2021-2032) & (US$ Million) Table 233. Egypt Insulin API Revenue (2021-2032) & (US$ Million) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. Insulin API Distributors List Table 237. Insulin API Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. Insulin API Image Figure 2. Global Insulin API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin API Market Size Share 2021 VS 2025 VS 2032 Figure 4. Regular Human Insulin Image Figure 5. Insulin Analogue Image Figure 6. Global Insulin API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Insulin API Market Size Share 2021 VS 2025 VS 2032 Figure 8. Fast-Acting Image Figure 9. Premix Image Figure 10. Long-Acting Image Figure 11. Global Insulin API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Insulin API Revenue (2021-2032) & (US$ Million) Figure 13. Global Insulin API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Insulin API Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Insulin API Revenue Market Share by Region (2021-2032) Figure 16. Global Insulin API Sales (2021-2032) & (Kg) Figure 17. Global Insulin API Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 18. Global Insulin API Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Insulin API Sales YoY (2021-2032) & (Kg) Figure 20. Europe Insulin API Sales YoY (2021-2032) & (Kg) Figure 21. China Insulin API Sales YoY (2021-2032) & (Kg) Figure 22. Asia (Excluding China) Insulin API Sales YoY (2021-2032) & (Kg) Figure 23. South America, Middle East and Africa Insulin API Sales YoY (2021-2032) & (Kg) Figure 24. Global Insulin API Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Insulin API Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Insulin API Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Insulin API Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Insulin API Revenue Market Share by Type (2021-2032) Figure 30. Global Insulin API Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 31. Global Insulin API Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Insulin API Sales Market Share by Type (2021-2032) Figure 33. Global Insulin API Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Insulin API Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Insulin API Revenue Market Share by Application (2021-2032) Figure 36. Global Insulin API Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 37. Global Insulin API Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Insulin API Sales Market Share by Application (2021-2032) Figure 39. North America Insulin API Revenue Share by Type (2021-2032) Figure 40. North America Insulin API Sales Share by Type (2021-2032) Figure 41. North America Insulin API Revenue Share by Application (2021-2032) Figure 42. North America Insulin API Sales Share by Application (2021-2032) Figure 43. North America Insulin API Revenue Share by Country (2021-2032) Figure 44. North America Insulin API Sales Share by Country (2021-2032) Figure 45. Europe Insulin API Revenue Share by Type (2021-2032) Figure 46. Europe Insulin API Sales Share by Type (2021-2032) Figure 47. Europe Insulin API Revenue Share by Application (2021-2032) Figure 48. Europe Insulin API Sales Share by Application (2021-2032) Figure 49. Europe Insulin API Revenue Share by Country (2021-2032) Figure 50. Europe Insulin API Sales Share by Country (2021-2032) Figure 51. China Insulin API Revenue Share by Type (2021-2032) Figure 52. China Insulin API Sales Share by Type (2021-2032) Figure 53. China Insulin API Revenue Share by Application (2021-2032) Figure 54. China Insulin API Sales Share by Application (2021-2032) Figure 55. Asia Insulin API Revenue Share by Type (2021-2032) Figure 56. Asia Insulin API Sales Share by Type (2021-2032) Figure 57. Asia Insulin API Revenue Share by Application (2021-2032) Figure 58. Asia Insulin API Sales Share by Application (2021-2032) Figure 59. Asia Insulin API Revenue Share by Country (2021-2032) Figure 60. Asia Insulin API Sales Share by Country (2021-2032) Figure 61. SAMEA Insulin API Revenue Share by Type (2021-2032) Figure 62. SAMEA Insulin API Sales Share by Type (2021-2032) Figure 63. SAMEA Insulin API Revenue Share by Application (2021-2032) Figure 64. SAMEA Insulin API Sales Share by Application (2021-2032) Figure 65. SAMEA Insulin API Revenue Share by Country (2021-2032) Figure 66. SAMEA Insulin API Sales Share by Country (2021-2032) Figure 67. Insulin API Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Insulin API Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Regular Human Insulin
  • Insulin Analogue
Applications
  • Fast-Acting
  • Premix
  • Long-Acting
Companies covered
  • Novo Nordisk
  • Sanofi-Aventis
  • Eli Lilly
  • Tonghua Dongbao
  • Ganlee
  • United Laboratory
  • Biocon
  • Amphastar
  • Wockhardt
  • Julphar Diabetes
  • Torrent Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Insulin API Market by Type
  3. 1.2.1 Global Insulin API Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Regular Human Insulin
  5. 1.2.3 Insulin Analogue
  6. 1.3 Insulin API Market by Application
  7. 1.3.1 Global Insulin API Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Fast-Acting
  9. 1.3.3 Premix
  10. 1.3.4 Long-Acting
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Insulin API Market Dynamics
  1. 2.1 Insulin API Industry Trends
  2. 2.2 Insulin API Industry Drivers
  3. 2.3 Insulin API Industry Opportunities and Challenges
  4. 2.4 Insulin API Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Insulin API Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Insulin API Revenue by Region
  3. 3.2.1 Global Insulin API Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Insulin API Revenue by Region (2021-2026)
  5. 3.2.3 Global Insulin API Revenue by Region (2027-2032)
  6. 3.2.4 Global Insulin API Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Insulin API Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Insulin API Sales by Region
  9. 3.4.1 Global Insulin API Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Insulin API Sales by Region (2021-2026)
  11. 3.4.3 Global Insulin API Sales by Region (2027-2032)
  12. 3.4.4 Global Insulin API Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Insulin API Revenue by Manufacturers
  2. 4.1.1 Global Insulin API Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Insulin API Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Insulin API Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Insulin API Sales by Manufacturers
  6. 4.2.1 Global Insulin API Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Insulin API Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Insulin API Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Insulin API Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Insulin API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Insulin API Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Insulin API Manufacturers, Product Type & Application
  13. 4.7 Global Insulin API Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Insulin API Market CR5 and HHI
  16. 4.8.2 2025 Insulin API Tier 1, Tier 2, and Tier 3
5 Insulin API Market by Type
  1. 5.1 Global Insulin API Revenue by Type
  2. 5.1.1 Global Insulin API Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Insulin API Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Insulin API Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Insulin API Sales by Type
  6. 5.2.1 Global Insulin API Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Insulin API Sales by Type (2021-2032) & (Kg)
  8. 5.2.3 Global Insulin API Sales Market Share by Type (2021-2032)
  9. 5.3 Global Insulin API Price by Type
6 Insulin API Market by Application
  1. 6.1 Global Insulin API Revenue by Application
  2. 6.1.1 Global Insulin API Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Insulin API Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Insulin API Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Insulin API Sales by Application
  6. 6.2.1 Global Insulin API Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Insulin API Sales by Application (2021-2032) & (Kg)
  8. 6.2.3 Global Insulin API Sales Market Share by Application (2021-2032)
  9. 6.3 Global Insulin API Price by Application
7 Company Profiles
  1. 7.1 Novo Nordisk
  2. 7.1.1 Novo Nordisk Company Information
  3. 7.1.2 Novo Nordisk Business Overview
  4. 7.1.3 Novo Nordisk Insulin API Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novo Nordisk Insulin API Product Portfolio
  6. 7.1.5 Novo Nordisk Recent Developments
  7. 7.2 Sanofi-Aventis
  8. 7.2.1 Sanofi-Aventis Company Information
  9. 7.2.2 Sanofi-Aventis Business Overview
  10. 7.2.3 Sanofi-Aventis Insulin API Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi-Aventis Insulin API Product Portfolio
  12. 7.2.5 Sanofi-Aventis Recent Developments
  13. 7.3 Eli Lilly
  14. 7.3.1 Eli Lilly Company Information
  15. 7.3.2 Eli Lilly Business Overview
  16. 7.3.3 Eli Lilly Insulin API Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly Insulin API Product Portfolio
  18. 7.3.5 Eli Lilly Recent Developments
  19. 7.4 Tonghua Dongbao
  20. 7.4.1 Tonghua Dongbao Company Information
  21. 7.4.2 Tonghua Dongbao Business Overview
  22. 7.4.3 Tonghua Dongbao Insulin API Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Tonghua Dongbao Insulin API Product Portfolio
  24. 7.4.5 Tonghua Dongbao Recent Developments
  25. 7.5 Ganlee
  26. 7.5.1 Ganlee Company Information
  27. 7.5.2 Ganlee Business Overview
  28. 7.5.3 Ganlee Insulin API Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Ganlee Insulin API Product Portfolio
  30. 7.5.5 Ganlee Recent Developments
  31. 7.6 United Laboratory
  32. 7.6.1 United Laboratory Company Information
  33. 7.6.2 United Laboratory Business Overview
  34. 7.6.3 United Laboratory Insulin API Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 United Laboratory Insulin API Product Portfolio
  36. 7.6.5 United Laboratory Recent Developments
  37. 7.7 Biocon
  38. 7.7.1 Biocon Company Information
  39. 7.7.2 Biocon Business Overview
  40. 7.7.3 Biocon Insulin API Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Biocon Insulin API Product Portfolio
  42. 7.7.5 Biocon Recent Developments
  43. 7.8 Amphastar
  44. 7.8.1 Amphastar Company Information
  45. 7.8.2 Amphastar Business Overview
  46. 7.8.3 Amphastar Insulin API Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Amphastar Insulin API Product Portfolio
  48. 7.8.5 Amphastar Recent Developments
  49. 7.9 Wockhardt
  50. 7.9.1 Wockhardt Company Information
  51. 7.9.2 Wockhardt Business Overview
  52. 7.9.3 Wockhardt Insulin API Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Wockhardt Insulin API Product Portfolio
  54. 7.9.5 Wockhardt Recent Developments
  55. 7.10 Julphar Diabetes
  56. 7.10.1 Julphar Diabetes Company Information
  57. 7.10.2 Julphar Diabetes Business Overview
  58. 7.10.3 Julphar Diabetes Insulin API Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Julphar Diabetes Insulin API Product Portfolio
  60. 7.10.5 Julphar Diabetes Recent Developments
  61. 7.11 Torrent Pharma
  62. 7.11.1 Torrent Pharma Company Information
  63. 7.11.2 Torrent Pharma Business Overview
  64. 7.11.3 Torrent Pharma Insulin API Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Torrent Pharma Insulin API Product Portfolio
  66. 7.11.5 Torrent Pharma Recent Developments
8 North America
  1. 8.1 North America Insulin API Market Size by Type
  2. 8.1.1 North America Insulin API Revenue by Type (2021-2032)
  3. 8.1.2 North America Insulin API Sales by Type (2021-2032)
  4. 8.1.3 North America Insulin API Price by Type (2021-2032)
  5. 8.2 North America Insulin API Market Size by Application
  6. 8.2.1 North America Insulin API Revenue by Application (2021-2032)
  7. 8.2.2 North America Insulin API Sales by Application (2021-2032)
  8. 8.2.3 North America Insulin API Price by Application (2021-2032)
  9. 8.3 North America Insulin API Market Size by Country
  10. 8.3.1 North America Insulin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Insulin API Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Insulin API Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Insulin API Market Size by Type
  2. 9.1.1 Europe Insulin API Revenue by Type (2021-2032)
  3. 9.1.2 Europe Insulin API Sales by Type (2021-2032)
  4. 9.1.3 Europe Insulin API Price by Type (2021-2032)
  5. 9.2 Europe Insulin API Market Size by Application
  6. 9.2.1 Europe Insulin API Revenue by Application (2021-2032)
  7. 9.2.2 Europe Insulin API Sales by Application (2021-2032)
  8. 9.2.3 Europe Insulin API Price by Application (2021-2032)
  9. 9.3 Europe Insulin API Market Size by Country
  10. 9.3.1 Europe Insulin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Insulin API Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Insulin API Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Insulin API Market Size by Type
  2. 10.1.1 China Insulin API Revenue by Type (2021-2032)
  3. 10.1.2 China Insulin API Sales by Type (2021-2032)
  4. 10.1.3 China Insulin API Price by Type (2021-2032)
  5. 10.2 China Insulin API Market Size by Application
  6. 10.2.1 China Insulin API Revenue by Application (2021-2032)
  7. 10.2.2 China Insulin API Sales by Application (2021-2032)
  8. 10.2.3 China Insulin API Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Insulin API Market Size by Type
  2. 11.1.1 Asia Insulin API Revenue by Type (2021-2032)
  3. 11.1.2 Asia Insulin API Sales by Type (2021-2032)
  4. 11.1.3 Asia Insulin API Price by Type (2021-2032)
  5. 11.2 Asia Insulin API Market Size by Application
  6. 11.2.1 Asia Insulin API Revenue by Application (2021-2032)
  7. 11.2.2 Asia Insulin API Sales by Application (2021-2032)
  8. 11.2.3 Asia Insulin API Price by Application (2021-2032)
  9. 11.3 Asia Insulin API Market Size by Country
  10. 11.3.1 Asia Insulin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Insulin API Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Insulin API Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Insulin API Market Size by Type
  2. 12.1.1 SAMEA Insulin API Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Insulin API Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Insulin API Price by Type (2021-2032)
  5. 12.2 SAMEA Insulin API Market Size by Application
  6. 12.2.1 SAMEA Insulin API Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Insulin API Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Insulin API Price by Application (2021-2032)
  9. 12.3 SAMEA Insulin API Market Size by Country
  10. 12.3.1 SAMEA Insulin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Insulin API Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Insulin API Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Insulin API Value Chain Analysis
  2. 13.1.1 Insulin API Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Insulin API Production Mode & Process
  6. 13.2 Insulin API Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Insulin API Distributors
  9. 13.2.3 Insulin API Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst